Faculty

Back to Index
Amir Goldkorn, MD
Associate Professor of Medicine
Medicine
NOR 3444 Health Sciences Campus Los Angeles
+1 323 442 7721

Overview

Dr. Goldkorn’s laboratory-based research program focuses on developing the therapeutic and biomarker potential of circulating tumor cells, cancer stem cells, and telomerase. Graduate students, postdocs and medical students in the laboratory conduct experiments ranging from basic molecular research to translational medicine assays for clinical trials. These research activities synergize with our clinical activities and provide unique opportunities to translate our laboratory and clinical advances into better care for our patients.

Dr. Goldkorn earned his medical degree from the UCLA School of Medicine. He then went on to complete his fellowship in hematology-oncology and post-doctoral research at University of California, San Francisco.

Awards

Harvard University: Harvard College Scholarship, 1990-1994

American Society of Clinical Oncology: Young Investigator Award, 2006-2007

UCLA School of Medicine: Letters of Distinction, 1996-1997

Western Society of Clinical Investigation: Elected Member, 2014

American Society of Clinical Oncology: Merit Award, 2012

American Federation for Medical Research: Outstanding Investigator Award, 2015

Stop Cancer Foundation: Research Career Development Award, 2007-2010

American Federation for Medical Research: award conferred by, 2015

Stop Cancer Foundation: award conferred by, 2007-2010

UCLA School of Medicine: award conferred by, 1996-1997

American Society of Clinical Oncology: award conferred by, 2006-2007

Harvard University: award conferred by, 1990-1994

Western Society of Clinical Investigation: award conferred by, 2014

American Society of Clinical Oncology: award conferred by, 2012

Harvard University: has faculty rank, 1990-1994

American Society of Clinical Oncology: has faculty rank, 2006-2007

UCLA School of Medicine: has faculty rank, 1996-1997

Stop Cancer Foundation: has faculty rank, 2007-2010

American Federation for Medical Research: has faculty rank, 2015

American Society of Clinical Oncology: has faculty rank, 2012

Western Society of Clinical Investigation: has faculty rank, 2014

American Society of Clinical Oncology: award or honor for, 2006-2007

American Federation for Medical Research: award or honor for, 2015

American Society of Clinical Oncology: award or honor for, 2012

Harvard University: award or honor for, 1990-1994

Stop Cancer Foundation: award or honor for, 2007-2010

UCLA School of Medicine: award or honor for, 1996-1997

Western Society of Clinical Investigation: award or honor for, 2014

Western Society of Clinical Investigation: full name, 2014

American Society of Clinical Oncology: full name, 2012

Harvard University: full name, 1990-1994

Stop Cancer Foundation: full name, 2007-2010

American Federation for Medical Research: full name, 2015

UCLA School of Medicine: full name, 1996-1997

American Society of Clinical Oncology: person in primary position, 2012

American Federation for Medical Research: person in primary position, 2015

Western Society of Clinical Investigation: person in primary position, 2014

Stop Cancer Foundation: person in primary position, 2007-2010

American Society of Clinical Oncology: person in primary position, 2006-2007

Harvard University: person in primary position, 1990-1994

UCLA School of Medicine: person in primary position, 1996-1997

UCLA School of Medicine: last name, 1996-1997

Harvard University: last name, 1990-1994

American Federation for Medical Research: last name, 2015

American Society of Clinical Oncology: last name, 2012

American Society of Clinical Oncology: last name, 2006-2007

Stop Cancer Foundation: last name, 2007-2010

Western Society of Clinical Investigation: last name, 2014

Harvard University: HR job title, 1990-1994

American Society of Clinical Oncology: HR job title, 2012

Stop Cancer Foundation: HR job title, 2007-2010

American Society of Clinical Oncology: HR job title, 2006-2007

UCLA School of Medicine: HR job title, 1996-1997

Western Society of Clinical Investigation: HR job title, 2014

American Federation for Medical Research: HR job title, 2015

American Society of Clinical Oncology: full name, 2006-2007

Western Society of Clinical Investigation: position in department, 2014

Harvard University: position in department, 1990-1994

Stop Cancer Foundation: position in department, 2007-2010

American Federation for Medical Research: position in department, 2015

American Society of Clinical Oncology: position in department, 2006-2007

American Society of Clinical Oncology: position in department, 2012

UCLA School of Medicine: position in department, 1996-1997

Harvard University: Faculty Rank, 1990-1994

Stop Cancer Foundation: Faculty Rank, 2007-2010

American Society of Clinical Oncology: Faculty Rank, 2006-2007

UCLA School of Medicine: Faculty Rank, 1996-1997

Western Society of Clinical Investigation: Faculty Rank, 2014

American Society of Clinical Oncology: Faculty Rank, 2012

American Federation for Medical Research: Faculty Rank, 2015

American Society of Clinical Oncology: sort order, 2012

Stop Cancer Foundation: sort order, 2007-2010

UCLA School of Medicine: sort order, 1996-1997

American Society of Clinical Oncology: sort order, 2006-2007

American Federation for Medical Research: sort order, 2015

Harvard University: sort order, 1990-1994

Western Society of Clinical Investigation: sort order, 2014

American Society of Clinical Oncology: Organization, 2012

Harvard University: Organization, 1990-1994

UCLA School of Medicine: Organization, 1996-1997

Western Society of Clinical Investigation: Organization, 2014

American Society of Clinical Oncology: Organization, 2006-2007

Stop Cancer Foundation: Organization, 2007-2010

UCLA School of Medicine: email address, 1996-1997

American Society of Clinical Oncology: email address, 2012

Stop Cancer Foundation: email address, 2007-2010

American Society of Clinical Oncology: email address, 2006-2007

Harvard University: email address, 1990-1994

American Federation for Medical Research: email address, 2015

Western Society of Clinical Investigation: email address, 2014

Harvard University: start date, 1990-1994

Stop Cancer Foundation: start date, 2007-2010

American Society of Clinical Oncology: start date, 2006-2007

Western Society of Clinical Investigation: start date, 2014

American Society of Clinical Oncology: start date, 2012

American Federation for Medical Research: start date, 2015

American Society of Clinical Oncology: Associate Professor of Medicine, 2012

Western Society of Clinical Investigation: Associate Professor of Medicine, 2014

Stop Cancer Foundation: Associate Professor of Medicine, 2007-2010

Harvard University: Associate Professor of Medicine, 1990-1994

American Federation for Medical Research: Associate Professor of Medicine, 2015

American Society of Clinical Oncology: Associate Professor of Medicine, 2006-2007

UCLA School of Medicine: Associate Professor of Medicine, 1996-1997

Stop Cancer Foundation: end date, 2007-2010

UCLA School of Medicine: end date, 1996-1997

Harvard University: end date, 1990-1994

American Society of Clinical Oncology: end date, 2006-2007

American Federation for Medical Research: Person ID, 2015

American Society of Clinical Oncology: Person ID, 2012

American Society of Clinical Oncology: Person ID, 2006-2007

Stop Cancer Foundation: Person ID, 2007-2010

Western Society of Clinical Investigation: Person ID, 2014

UCLA School of Medicine: Person ID, 1996-1997

UCLA School of Medicine: Keck School of Medicine of USC, 1996-1997

Harvard University: Keck School of Medicine of USC, 1990-1994

Stop Cancer Foundation: Keck School of Medicine of USC, 2007-2010

American Society of Clinical Oncology: Keck School of Medicine of USC, 2012

American Federation for Medical Research: Keck School of Medicine of USC, 2015

American Society of Clinical Oncology: Keck School of Medicine of USC, 2006-2007

Western Society of Clinical Investigation: Keck School of Medicine of USC, 2014

UCLA School of Medicine: Associate Professor, 1996-1997

Western Society of Clinical Investigation: Associate Professor, 2014

Stop Cancer Foundation: Associate Professor, 2007-2010

American Society of Clinical Oncology: Associate Professor, 2012

American Society of Clinical Oncology: Associate Professor, 2006-2007

Harvard University: Associate Professor, 1990-1994

American Federation for Medical Research: Associate Professor, 2015

UCLA School of Medicine: label, 1996-1997

Stop Cancer Foundation: label, 2007-2010

American Society of Clinical Oncology: label, 2012

American Federation for Medical Research: label, 2015

Western Society of Clinical Investigation: label, 2014

American Society of Clinical Oncology: label, 2006-2007

Harvard University: position in organization, 1990-1994

American Society of Clinical Oncology: position in organization, 2006-2007

Stop Cancer Foundation: position in organization, 2007-2010

Western Society of Clinical Investigation: position in organization, 2014

UCLA School of Medicine: position in organization, 1996-1997

American Society of Clinical Oncology: position in organization, 2012

American Federation for Medical Research: position in organization, 2015

UCLA School of Medicine: is primary position, 1996-1997

Western Society of Clinical Investigation: is primary position, 2014

American Society of Clinical Oncology: is primary position, 2012

Harvard University: is primary position, 1990-1994

Stop Cancer Foundation: is primary position, 2007-2010

American Society of Clinical Oncology: is primary position, 2006-2007

American Federation for Medical Research: is primary position, 2015

American Federation for Medical Research: Organization, 2015

UCLA School of Medicine: Person, 1996-1997

Western Society of Clinical Investigation: Person, 2014

Harvard University: Person, 1990-1994

American Society of Clinical Oncology: Person, 2006-2007

American Society of Clinical Oncology: Person, 2012

American Federation for Medical Research: Person, 2015

American Federation for Medical Research: preferred title, 2015

Western Society of Clinical Investigation: preferred title, 2014

Harvard University: preferred title, 1990-1994

American Society of Clinical Oncology: preferred title, 2012

UCLA School of Medicine: preferred title, 1996-1997

American Society of Clinical Oncology: preferred title, 2006-2007

Stop Cancer Foundation: preferred title, 2007-2010

American Society of Clinical Oncology: Agent, 2006-2007

American Society of Clinical Oncology: Agent, 2012

UCLA School of Medicine: Agent, 1996-1997

Harvard University: Agent, 1990-1994

Stop Cancer Foundation: Agent, 2007-2010

Western Society of Clinical Investigation: Agent, 2014

American Federation for Medical Research: Agent, 2015

Harvard University: first name, 1990-1994

UCLA School of Medicine: first name, 1996-1997

American Society of Clinical Oncology: first name, 2012

American Federation for Medical Research: first name, 2015

American Society of Clinical Oncology: first name, 2006-2007

Stop Cancer Foundation: first name, 2007-2010

Western Society of Clinical Investigation: first name, 2014

UCLA School of Medicine: start date, 1996-1997

Harvard University: Person ID, 1990-1994

UCLA School of Medicine: Position, 1996-1997

Harvard University: Position, 1990-1994

American Federation for Medical Research: Position, 2015

Western Society of Clinical Investigation: Position, 2014

American Society of Clinical Oncology: Position, 2012

Stop Cancer Foundation: Position, 2007-2010

American Society of Clinical Oncology: Position, 2006-2007

American Society of Clinical Oncology: Goldkorn, Amir, 2012

American Federation for Medical Research: Goldkorn, Amir, 2015

Western Society of Clinical Investigation: Goldkorn, Amir, 2014

Stop Cancer Foundation: Goldkorn, Amir, 2007-2010

UCLA School of Medicine: Goldkorn, Amir, 1996-1997

American Society of Clinical Oncology: Goldkorn, Amir, 2006-2007

Harvard University: Goldkorn, Amir, 1990-1994

Stop Cancer Foundation: photo, 2007-2010

American Society of Clinical Oncology: photo, 2012

Harvard University: photo, 1990-1994

UCLA School of Medicine: photo, 1996-1997

American Society of Clinical Oncology: photo, 2006-2007

American Federation for Medical Research: photo, 2015

Western Society of Clinical Investigation: photo, 2014

Publications

Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine. Front Oncol. 2017; 7:6. View in: PubMed

AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth. Prostate. 2016 May; 76(6):597-608. View in: PubMed

Telomere and Telomerase Therapeutics in Cancer. Genes (Basel). 2016; 7(6). View in: PubMed

Editorial Comment. J Urol. 2015 Sep; 194(3):798. View in: PubMed

Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy. J Natl Cancer Inst. 2015 Jul; 107(7). View in: PubMed

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial. Int J Cancer. 2015 Apr 15; 136(8):1856-62. View in: PubMed

Circulating tumor cells in prostate cancer: a better predictor of survival than prostate specific antigen? Expert Rev Anticancer Ther. Circulating tumor cells in prostate cancer: a better predictor of survival than prostate specific antigen? Expert Rev Anticancer Ther. 2014 Nov; 14(11):1257-60. View in: PubMed

New prostate cancer drugs: extending and improving life. Lancet Oncol. 2014 Sep; 15(10):1052-4. View in: PubMed

Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol. 2014 Apr 10; 32(11):1136-42. View in: PubMed

Serum Biomarkers of Bone Metabolism in Castration-Resistant Prostate Cancer Patients With Skeletal Metastases: Results From SWOG 0421. J Natl Cancer Inst. 2014 Apr 1; 106(4):dju013. View in: PubMed

Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/ß-catenin/CBP pathway. Int J Cancer. 2014 Jan 1; 134(1):43-54. View in: PubMed

Efficacy of oxaliplatin plus pemetrexed in chemotherapy pretreated metastatic castration-resistant prostate cancer. Clin Genitourin Cancer. 2013 Dec; 11(4):416-22. View in: PubMed

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial. Lancet Oncol. 2013 Aug; 14(9):893-900. View in: PubMed

Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shore. Ann Oncol. 2013 Jul; 24(7):1717-20. View in: PubMed

Circulating tumor cells in prostate cancer. Cancers (Basel). 2013; 5(4):1676-90. View in: PubMed

Perillyl alcohol for the treatment of temozolomide-resistant gliomas. Mol Cancer Ther. 2012 Nov; 11(11):2462-72. View in: PubMed

Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference. Prostate. 2011 Sep 15; 71(13):1390-400. View in: PubMed

Telomerase targeted therapy in cancer and cancer stem cells. Clin Adv Hematol Oncol. 2011 Jun; 9(6):442-55. View in: PubMed

Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype. Mol Cancer Ther. 2011 Jun; 10(6):938-48. View in: PubMed

A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. Cancer Res. 2010 Aug 15; 70(16):6420-6. View in: PubMed

Reprogramming murine telomerase rapidly inhibits the growth of mouse cancer cells in vitro and in vivo. Mol Cancer Ther. 2010 Feb; 9(2):438-49. View in: PubMed

Targeted therapy in renal cancer. Ther Adv Med Oncol. 2009 Nov; 1(3):183-205. View in: PubMed

Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells. Cancer Res. 2006 Jun 1; 66(11):5763-71. View in: PubMed

Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb Cortex. 1998 Sep; 8(6):492-509. View in: PubMed

Sulcal variability in the Alzheimer's brain: correlations with cognition. Neurology. 1998 Jan; 50(1):145-51. View in: PubMed

Powered bySC CTSI